Design, Science and Technology

A new discovery in the fight against COVID-19 could lead to a long-lasting vaccine that works on all currently known variants of the ever-mutating virus. With new COVID variants and subvariants evolving faster and faster, each chipping away at the effectiveness of the leading vaccines, the hunt is on for a new kind of vaccine — one that works equally well on current and future forms of a novel coronavirus.

 

 

Read the full article at: www.thedailybeast.com

Via Juan Lama, Dr. Stefan Gruenwald

In 2017, three leading vaccine researchers submitted a grant application with an ambitious goal. At the time, no one had proved a vaccine could stop even a single beta coronavirus—the notorious viral group then known to include the lethal agents of severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS), as well as several causes of the common cold and many bat viruses. But these researchers wanted to develop a vaccine against them all. Grant reviewers at the National Institute of Allergy and Infectious Diseases (NIAID) deemed the plan “outstanding.” But they gave the proposal a low priority score, dooming its bid for funding.

 

https://doi.org/10.1126/science.abi9939

Read the full article at: www.sciencemag.org

Via Juan Lama, Dr. Stefan Gruenwald